Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies from University of Oxford research
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.